Skip to main content
. 2012 Dec 5;367(1607):3364–3378. doi: 10.1098/rstb.2011.0389

Table 1.

Preclinical and clinical studies investigating the anxiolytic properties of CBD. ↓, anxiolytic effect; ↑, anxiogenic effect; CFC, contextual fear conditioning; EPM, elevated plus maze; ETM, elevated T maze; GAD, generalized anxiety patients; OF, open field; VCT, Vogel conflict test; i.p., intraperitoneal injection; i.c.v., intracerebroventricular injection; DPAG, dorsal periaqueductal grey; BNST, bed nucleus of the stria terminalis; PL, prelimbic cortex; IL, infralimbic cortex; CeA, central amygdala.

model species effective doses CBD effect references
studies with laboratory animals
Geller-Seifter conflict model rat 100 mg kg−1 i.p. no effect [5]
conditioned emotional responses rat 10 mg kg−1 i.p. [6]
EPM rat 2.5–10 mg kg−1 i.p [7]
EPM mouse 1–10 mg kg−1 i.p. [8]
VCT rat 10 mg kg−1 [9]
CFC rat 10 mg kg−1 i.p. ↓; decreased autonomic responses [10]
predator exposure (Cat)+ EPM rat 5 mg kg−1 [11]
restraint stress + EPM rat 30 nmol intra-cisterna magna decreased autonomic and delayed anxiogenic effect [12]
predator exposure (snake) mouse 3–30 mg kg−1 i.p. panicolytic [13]
marble burying mouse 30 mg kg−1 i.p decreased compulsive behaviour [14]
CFC/fear memory extinction rat 6.35 nmol i.c.v. ↓; facilitated extinction [15]
ETM/DPAG electric stimulation rat 30–60 nmol intra-DPAG ↓, panicolytic [16]
restraint stress + EPM rat 10 mg kg−1 i.p. decreased autonomic and delayed anxiogenic effect [17]
EPM/VCT rat 15–30 nmol intra-DPAG [18]
EPM/VCT rat 30–60 nmol intra-BNST [19]
CFC rat 30–60 nmol intra-BNST ↓, decreased autonomic responses [20]
CFC rat 30 nmol intra-PL [21]
CFC rat 30 nmol intra-IL [21]
CFC rat 10 mg kg−1 i.p./daily/14 days [22]
CFC/fear reconsolidation rat 10 mg kg−1 i.p. ↓; memory reconsolidation impairment [23]
model/measures subjects dose (mg, p.o.) CBD effect references
clinical studies
simulated public-speaking healthy volunteers 400 mg [24]
neuroimaging study healthy volunteers 400 mg [25]
fearful facial stimuli healthy volunteers 600 mg [26]
fearful facial stimuli healthy volunteers 600 mg [27]
anxiety symptoms (visual analogue mood scale) GAD 400 mg [28]
simulated public speaking social phobics 400 mg [29]